Safety Shot Releases Second Quarter 2024 Results and Corporate Highlights
- Q2 Revenues Increased 40%- Q2 Operating Expenses Decreased 17.7%- Recent Clinical Trial Confirms Dramatic Reduction of Blood Alcohol Content-...
DNA
The American Journal of Gastroenterology Publishes Esopredict Performance Results from Pivotal Clinical Validation Study
Results demonstrate Esopredict's ability to predict the likelihood of progression to high-grade dysplasia or esophageal adenocarcinoma in patients with Barrett's...
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.
SALT LAKE CITY, Aug. 15, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a...
Chromatography Market size is set to grow by USD 3.99 billion from 2024-2028, Increasing number of conferences and symposiums to boost the market growth, Technavio
NEW YORK, Aug. 14, 2024 /PRNewswire/ -- The global chromatography market size is estimated to grow by USD 3.99 billion...
Ludwig Announces Substantial Corporate Initiatives
Revealia™, the world’s most convenient cancer screening test, to launch in 2024 SPARKS, NV / ACCESSWIRE / August 14, 2024...
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
Declared development candidate MGX-001 for the treatment of hemophilia A; plans to present 12-month NHP durability study data in September...
IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:...
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun...
Colorectal Cancer and Gut Health: Insights from Dr. Richard Birkett
BOSTON, MA / ACCESSWIRE / August 13, 2024 / Colorectal cancer, a serious condition affecting the colon or rectum, is...
Corewell Health and Gift of Life Michigan Launch InVita Healthcare Technologies’ iReferral in Nation’s Largest Launch to-date, Streamlining Critical Donor Referral Process
iReferral® automatically identifies potential organ and tissue donors and streamlines the hospital-to-OPO referral process. ANN ARBOR, Mich., Aug. 13, 2024...
Lexicon Pharmaceuticals Announces Strategic Repositioning to Drive Value and Growth of Commercial Portfolio
Company to Focus on Targeted Promotion of INPEFA® in Heart Failure While Prioritizing Investment in the Potential Launch of ZYNQUISTA™...
Defence Therapeutics Collaboration Agreement with Orano to Develop the Next Generation of Targeted Radio-Immunotherapy for Cancer Advances
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
MedEvolve Rated Top Revenue Cycle Management Workflow Optimization and Automation Solution, 2024 Black Book RCM Client Survey
TAMPA, FL / ACCESSWIRE / August 9, 2024 / Black Book Research announces that MedEvolve has been named the top...
Ginkgo Bioworks Reports Second Quarter 2024 Financial Results
Ginkgo provides update on its restructuring process including estimated annualized cost savings of over $85 million from reduction in force ...
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
- Conference Call/Webcast Scheduled for Today at 4:30 PM ET - STONY BROOK, NY / ACCESSWIRE / August 8, 2024...
Electromedical Provides Update to Shareholders
Electromedical (EMED), a Leader in Bioelectronic Medical Devices, Updates Shareholders on Recent Achievements and Strategic AdvancementsSCOTTSDALE, AZ / ACCESSWIRE /...
FOXO Technologies Subsidiary, Myrtle Recovery Centers, Receives Two Full Licenses from the Tennessee Department of Mental Health and Substance Abuse Services
MINNEAPOLIS, MN, Aug. 08, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced that its recently acquired subsidiary,...
Healthcare Sector Sees Steady Rise in VC Investment and Fundraising; Silicon Valley Bank Releases 14th Edition of Mid-Year Healthcare Investments and Exits Report
2024 shaping up to be a strong year for biopharma SAN FRANCISCO, Aug. 7, 2024 /PRNewswire/ -- In the first half...
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
STONY BROOK, NY / ACCESSWIRE / August 7, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),...
Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance
CAPLYTA Q2 2024 net product sales were $161.3 million, compared to $110.1 million for the same period in 2023, representing a...